z-logo
Premium
Cancer incidence and cancer control in M ongolia: Results from the N ational C ancer R egistry 2008–12
Author(s) -
Chimed Tuvshinjargal,
Sandagdorj Tuvshingerel,
Znaor Ariana,
Laversanne Mathieu,
Tseveen Badamsuren,
Genden Purevsuren,
Bray Freddie
Publication year - 2016
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.30463
Subject(s) - cancer , medicine , incidence (geometry) , cervical cancer , cancer registry , stomach cancer , population , liver cancer , cervix , cancer prevention , demography , environmental health , physics , sociology , optics
Mongolia has a high burden from noncommunicable diseases, with cancer now the second leading cause of mortality. Given the paucity of situation analyses from the country, this study reports cancer data based on new cases 2008–12 from the National Cancer Registry of Mongolia covering the entire population (2.87 million). New cancer cases of 21,564 were diagnosed over the 5‐year period, with a slight predominance of cases (52%) in men. Liver cancer was the leading cancer site in both sexes (ASRs of 114.7 and 74.6 per 100,000 males and females), and responsible for almost two‐fifths of all cancer diagnoses, followed by cancers of stomach, lung and oesophagus in men and cervix, stomach and oesophagus in women. The cumulative risk of incidence for all cancers (27.7% and 20.8% in men and women, respectively) positions Mongolia above China (20.2% and 13.3%), below the United States (34.1% and 28.5%) and similar to Russia (26.1% and 19.1%). These figures shed light on the considerable magnitude of cancer in the country and the large fraction of cancers that can be prevented by lifestyle modifications and vaccine implementation. An expansion of activities of the cancer registry and the continued development of research are necessary steps in support of national cancer control planning in Mongolia.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here